Mo. firm expected to benefit from Obama policy, stimulus plan

03/12/2009 | St. Louis Post-Dispatch

St. Louis-based Sigma-Aldrich, a provider of scientific kits and products for stem cell research, is one of the firms expected to benefit from the recent lifting of federal funding limits on embryonic stem cell research. The company also is looking to get a boost from the stimulus plan that allotted NIH funding for induced pluripotent stem cell research.

View Full Article in:

St. Louis Post-Dispatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ